Wondering what the changing NHS landscape could mean for patients, services, and clinical pathways? Merck UK & Ireland are excited to announce their new podcast series, NAVIGATE! NAVIGATE aims to educate listeners on the changing UK healthcare landscape and provide NHS stakeholders with recommendations on how they can support the optimal delivery of care in the fast-emerging integrated care landscape. Throughout this series, our Director of Market Access, Amerah Amin, will be joined by several leading experts from across the NHS, to explore different views on how service delivery is evolving in the NHS across a number of conditions, ranging from cancer to neurology care. In doing so, we will consider what exactly emerging Integrated Care Systems (ICSs) could mean for the NHS and the communities and individuals they serve. Stay tuned to catch future episodes of NAVIGATE and be part of this important conversation with Merck!
https://mercknavigate.podbean.com
episode 5: MS Services in England: Where are we now and where to next?
In the UK today there are around 130,000 people living with multiple sclerosis (MS) and nearly 7,000 individuals are diagnosed with this neurological condition each year.* The impact of MS varies significantly meaning effective care is reliant upon a diverse services landscape with access to multi-disciplinary teams, coordinated care, and choices in treatment. With the establishment last year of 42 new Integrated Care Systems which are gradually assuming responsibility for commissioning MS services, this landscape is evolving.
Check out the latest NAVIGATE episode where our Director of Market Access, Pricing and Government Affairs, Amerah Amin, sits down with Georgina Carr, CEO of the Neurological Alliance, and David Martin, CEO of the MS Trust, to discuss this evolution and gain their perspectives on how these changes can be harnessed to improve the UK’s MS services.
*MS Society, MS in the UK, accessed July 2023